Important notice regarding Rhopressa

Posted in Latest News on February 12, 2019.

The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa.



More Latest News

Notification of Renewal Deadline Extension
December 29, 2020

State Surgeon General Scott A. Rivkees issued Emergency Order 20-015 granting licensure renewal extensions
Continue reading


Potential Spam Alert
November 18, 2020

The Department of Health, Division of Medical Quality Assurance is warning Florida health care practitioners about fraudulent calls that have been received by multiple licensees.
Continue reading